-
3
-
-
34447104397
-
The fecal mi-crobiota of irritable bowel syndrome patients differs significantly from that of healthy subjects
-
Kassinen A, Krogius-Kurikka L, Mäkivuok-ko H, Rinttilä T, Paulin L, Corander J, Ma-linen E, Apajalahti J, Palva A: The fecal mi-crobiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33.
-
(2007)
Gastroenterology
, vol.133
, pp. 24-33
-
-
Kassinen, A.1
Krogius-Kurikka, L.2
Mäkivuok-Ko, H.3
Rinttilä, T.4
Paulin, L.5
Corander, J.6
Ma-Linen, E.7
Apajalahti, J.8
Palva, A.9
-
4
-
-
0036083346
-
Activation of the mucosal immune system in irritable bowel syndrome
-
Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Wilson I: Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122:1778-1783.
-
(2002)
Gastroenterology
, vol.122
, pp. 1778-1783
-
-
Chadwick, V.S.1
Chen, W.2
Shu, D.3
Paulus, B.4
Bethwaite, P.5
Tie, A.6
Wilson, I.7
-
5
-
-
15744374565
-
Lactoba-cillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles
-
O'Mahony L, McCarthy J, Kelly P, Röth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ, Holtmann G: Lactoba-cillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128:541-551.
-
(2005)
Gastroenterology
, vol.128
, pp. 541-551
-
-
O'Mahony, L.1
McCarthy, J.2
Kelly, P.3
Röth, A.4
Heinzel, S.5
Lester, S.6
Downie-Doyle, S.7
Smith, E.8
Drew, P.9
Talley, N.J.10
Holtmann, G.11
-
6
-
-
33947324517
-
Immune activation in patients with irritable bowel syndrome
-
Liebregts T, Adam B, Bredack C, et al: Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132: 913-9 2 0.
-
(2007)
Gastroenterology
, vol.132
, pp. 913-920
-
-
Liebregts, T.1
Adam, B.2
Bredack, C.3
-
7
-
-
84985161098
-
Probiotics in man and animals
-
Fuller R: Probiotics in man and animals. J Appl Bacteriol 1989; 66:365-378.
-
(1989)
J Appl Bacteriol
, vol.66
, pp. 365-378
-
-
Fuller, R.1
-
8
-
-
33846100339
-
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
-
Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, Ouwehand A, Leyer G, Carcano D, Colombel JF, Ardid D, Desreumaux P: Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13: 35-37.
-
(2007)
Nat Med
, vol.13
, pp. 35-37
-
-
Rousseaux, C.1
Thuru, X.2
Gelot, A.3
Barnich, N.4
Neut, C.5
Dubuquoy, L.6
Dubuquoy, C.7
Merour, E.8
Geboes, K.9
Chamaillard, M.10
Ouwehand, A.11
Leyer, G.12
Carcano, D.13
Colombel, J.F.14
Ardid, D.15
Desreumaux, P.16
-
9
-
-
69249145574
-
The efficacy of probiotics in the therapy of irri table bowel syndrome: A systematic review
-
Epub ahead of print
-
Moayyedi P, Ford AC, Talley NJ, et al: The efficacy of probiotics in the therapy of irri table bowel syndrome: a systematic review. Gut 2008, Epub ahead of print.
-
(2008)
Gut
-
-
Moayyedi, P.1
Ford, A.C.2
Talley, N.J.3
-
10
-
-
0036185671
-
Bifidobacterium animali s strain DN-173 010 shortens the colonic transit time in healthy women: A double-blind, randomized, controlled study
-
Marteau P, Cuillerier E, Meance S, Gerhardt MF, Myara A, Bouvier M, Bouley C, Tondu F, Bommelaer G, Grimaud JC: Bifidobacterium animali s strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. A liment Pha rmacol Ther 2002; 1 6: 587-593.
-
(2002)
A Liment Pha Rmacol Ther
, vol.1
, Issue.6
, pp. 587-593
-
-
Marteau, P.1
Cuillerier, E.2
Meance, S.3
Gerhardt, M.F.4
Myara, A.5
Bouvier, M.6
Bouley, C.7
Tondu, F.8
Bommelaer, G.9
Grimaud, J.C.10
-
11
-
-
0005200297
-
Effects of consumption of a milk fermented by a probiotic Bifidobacteri-um animalis (strain DN-173-010) on colonic transit times in healthy humans
-
Bouvier M, Méance S, Bouley C, Berta JL, Grimaud JC: Effects of consumption of a milk fermented by a probiotic Bifidobacteri-um animalis (strain DN-173-010) on colonic transit times in healthy humans. Biosci Mi-croflora 2001; 20:43-48.
-
(2001)
Biosci Mi-croflora
, vol.20
, pp. 43-48
-
-
Bouvier, M.1
Méance, S.2
Bouley, C.3
Berta, J.L.4
Grimaud, J.C.5
-
12
-
-
57649208538
-
Clinical trial: The effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation
-
Agrawa l A, Houghton LA, Morr is J, Reil ly B, Guyonnet D, Goupil Feuillerat N, Schlum-berger A, Jakob S, Whorwell PJ: Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2008; 29:104-114.
-
(2008)
Aliment Pharmacol Ther
, vol.29
, pp. 104-114
-
-
Agrawa, L.A.1
Houghton, L.A.2
Morr Is, J.3
Reil Ly, B.4
Guyonnet, D.5
Goupil Feuillerat, N.6
Schlum-Berger, A.7
Jakob, S.8
Whorwell, P.J.9
-
13
-
-
34447298145
-
Effect of a fermented milk containing Bifi-dobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double-blind, controlled trial
-
Guyonnet D, C hass a ny O, Duc rot t e P, P ic a rd C, Mouret M, Mercier CH, Matuchansky C: Effect of a fermented milk containing Bifi-dobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007; 26: 475-4 86.
-
(2007)
Aliment Pharmacol Ther
, vol.26
, pp. 475-486
-
-
Guyonnet, D.1
Chassany, O.2
Ducrotte, P.3
Picard, C.4
Mouret, M.5
Mercier, C.H.6
Matuchansky, C.7
-
14
-
-
60349087099
-
Fermented milk containing Bifidobacterium lactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults: A randomized, open-label, controlled, pilot study
-
Guyonnet D, Woodcock A, Stefani B, Tre-visan C, Hall C: Fermented milk containing Bifidobacterium lactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults: a randomized, open-label, controlled, pilot study. J Dig Dis 2009; 10:61-70.
-
(2009)
J Dig Dis
, vol.10
, pp. 61-70
-
-
Guyonnet, D.1
Woodcock, A.2
Stefani, B.3
Tre-Visan, C.4
Hall, C.5
-
15
-
-
73749083065
-
Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: A randomised, double-blind, parallel, controlled study
-
Guyonnet D, Schlumberger A, Mhamdi L, Jakob S, Chassany O: Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study. Br J Nutr 2009; 102:1654-1662.
-
(2009)
Br J Nutr
, vol.102
, pp. 1654-1662
-
-
Guyonnet, D.1
Schlumberger, A.2
Mhamdi, L.3
Jakob, S.4
Chassany, O.5
|